查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1467929

2024-2032 年氣霧劑輸送設備市場報告（按產品、應用（氣喘、慢性阻塞性肺病、囊性纖維化、非呼吸系統疾病）、配銷通路和地區）

Aerosol Delivery Devices Market Report by Product, Application (Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, Non-Respiratory Diseases), Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球氣霧劑輸送裝置市場規模達到 471 億美元。

氣霧劑輸送裝置用於藥物傳遞和治療呼吸系統疾病，例如氣喘、阻塞性肺病、囊性纖維化、肺動脈高壓、感染性肺病。它們降低了劑量需求，減少了全身不良反應並提高了患者自我用藥的能力。一些常用的氣霧劑輸送裝置是加壓定量吸入器、霧化器和帶閥的保持器室。目前，由於新型大分子藥物的出現，智慧氣霧劑給藥裝置被用於非呼吸系統疾病，如糖尿病、鎮痛、甲狀腺疾病和遺傳性疾病。

氣霧劑輸送裝置市場趨勢：

導致患者急性呼吸道感染的冠狀病毒疾病（COVID-19）在全球爆發，是推動氣霧劑輸送設備需求的關鍵因素之一。這些設備有助於在家中和醫療機構中治療阻塞性氣道疾病。除此之外，由於空氣污染水平、過敏原和職業風險的飆升，慢性呼吸道感染的盛行率不斷上升，以及吸菸和飲酒的人數不斷增加，正在推動市場的成長。此外，老年人口數量大幅增加，更容易患上嚴重的健康疾病，這對方便且經濟的攜帶式吸入裝置的需求產生了積極影響。除此之外，市場參與者正在開發新型氣霧劑輸送裝置，幫助治療肺部慢性發炎和感染，並改善囊性纖維化 (CF) 患者的氣道清除率。此外，他們還透過電子商務管道提供迷你超音波霧化器和吸入器，這些霧化器和吸入器具有自動記憶功能，易於在旅行時使用。這與個人化藥物治療的需求不斷成長以及擴大使用線上管道購買醫療用品相結合，正在推動市場的發展。

本報告回答的關鍵問題

  • 2023 年全球氣霧劑輸送設備市場規模有多大？
  • 2024-2032年全球氣霧劑輸送裝置市場的預期成長率是多少？
  • 推動全球氣霧劑輸送設備市場的關鍵因素是什麼？
  • COVID-19 對全球氣霧劑輸送設備市場有何影響？
  • 基於產品的全球氣霧劑輸送裝置市場的細分如何？
  • 根據配銷通路，全球氣霧劑輸送裝置市場的細分如何？
  • 全球氣霧劑輸送設備市場的關鍵區域有哪些？
  • 誰是全球氣霧劑輸送設備市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球氣霧劑輸送設備市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 乾粉吸入器
    • 市場走向
    • 關鍵環節
      • 單劑量吸入器
      • 多劑量吸入器
    • 市場預測
  • 定量吸入器
    • 市場走向
    • 關鍵環節
      • 傳統加壓吸入器
      • 軟霧吸入器
    • 市場預測
  • 霧化器
    • 市場走向
    • 關鍵環節
      • 噴射霧化器
      • 超音波霧化器
      • 振動網霧化器
    • 市場預測

第 7 章：市場區隔：按應用

  • 氣喘
    • 市場走向
    • 市場預測
  • 慢性阻塞性肺病（COPD）
    • 市場走向
    • 市場預測
  • 囊腫纖維化
    • 市場走向
    • 市場預測
  • 非呼吸系統疾病
    • 市場走向
    • 關鍵環節
      • 糖尿病
      • 鎮痛
      • 帕金森氏症
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 零售藥局
    • 市場走向
    • 市場預測
  • 醫院藥房
    • 市場走向
    • 市場預測
  • 網路商店
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • 3M Company
    • Aerogen
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Koninklijke Philips NV
    • Merck & Co. Inc.
    • Metall Zug AG
    • Recipharm AB (publ)
    • Teva Pharmaceutical Industries Ltd.
    • Vectura Group plc
Product Code: SR112024A4892

The global aerosol delivery devices market size reached US$ 47.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 73.4 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9% during 2024-2032.

Aerosol delivery devices are used in drug delivery and treating respiratory disorders, such as asthma, obstructive lung diseases, cystic fibrosis, pulmonary arterial hypertension, infectious pulmonary. They lower dosage requirements, reduce systemic adverse effects and improve the ability of patients to self-administer medication. Some of the commonly available aerosol delivery devices are pressurized metered-dose inhalers, nebulizers, and valved holder chambers. At present, smart aerosol drug delivery devices are used in non-respiratory conditions, such as diabetes, analgesia, thyroid disorders, and genetic diseases, due to the advent of novel macromolecular medications.

Aerosol Delivery Devices Market Trends:

The global outbreak of the coronavirus disease (COVID-19) that leads to acute respiratory infections among patients represents one of the key factors driving the need for aerosol delivery devices. These devices assist in treating obstructive airway diseases at home and in healthcare settings. Apart from this, the rising prevalence of chronic respiratory infections due to surging air pollution levels, allergens and occupational risks, and the increasing number of individuals who smoke tobacco and drink is propelling the market growth. Moreover, a considerable rise in the geriatric population, which is more vulnerable to developing serious health illnesses, is positively influencing the demand for portable inhalation devices that are convenient and economical. Besides this, market players are developing novel aerosol delivery devices that help treat chronic inflammation and infection in the lungs and improve airway clearance in patients with cystic fibrosis (CF). Furthermore, they are offering mini ultrasonic nebulizers and inhalers through e-commerce channels that have automatic memory and are easy to use while traveling. This, in confluence with the escalating demand for personalized drug therapy and the increasing use of online channels for purchasing medical supplies, is driving the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global aerosol delivery devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and distribution channel.

Breakup by Product:

Dry Powder Inhalers

Single Dose Inhalers

Multi Dose Inhalers

Metered Dose Inhalers

Conventional Pressurized Inhalers

Soft Mist Inhalers

Nebulizers

Jet Nebulizers

Ultrasonic Wave Nebulizers

Vibrating Mesh Nebulizers

Breakup by Application:

Asthma

Chronic Obstructive Pulmonary Disease (COPD)

Cystic Fibrosis

Non-Respiratory Diseases

Diabetes

Analgesia

Parkinson's Disease

Breakup by Distribution Channel:

Retail Pharmacies

Hospital Pharmacies

Online Stores

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Aerogen, GlaxoSmithKline plc, Johnson & Johnson, Koninklijke Philips N.V., Merck & Co. Inc., Metall Zug AG, Recipharm AB (publ), Teva Pharmaceutical Industries Ltd. and Vectura Group plc.

Key Questions Answered in This Report

  • 1. What was the size of the global aerosol delivery devices market in 2023?
  • 2. What is the expected growth rate of the global aerosol delivery devices market during 2024-2032?
  • 3. What are the key factors driving the global aerosol delivery devices market?
  • 4. What has been the impact of COVID-19 on the global aerosol delivery devices market?
  • 5. What is the breakup of the global aerosol delivery devices market based on the product?
  • 6. What is the breakup of the global aerosol delivery devices market based on the distribution channel?
  • 7. What are the key regions in the global aerosol delivery devices market?
  • 8. Who are the key players/companies in the global aerosol delivery devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Aerosol Delivery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Dry Powder Inhalers
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Single Dose Inhalers
      • 6.1.2.2 Multi Dose Inhalers
    • 6.1.3 Market Forecast
  • 6.2 Metered Dose Inhalers
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Conventional Pressurized Inhalers
      • 6.2.2.2 Soft Mist Inhalers
    • 6.2.3 Market Forecast
  • 6.3 Nebulizers
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Jet Nebulizers
      • 6.3.2.2 Ultrasonic Wave Nebulizers
      • 6.3.2.3 Vibrating Mesh Nebulizers
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Asthma
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chronic Obstructive Pulmonary Disease (COPD)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cystic Fibrosis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Non-Respiratory Diseases
    • 7.4.1 Market Trends
    • 7.4.2 Key Segments
      • 7.4.2.1 Diabetes
      • 7.4.2.2 Analgesia
      • 7.4.2.3 Parkinson's Disease
    • 7.4.3 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospital Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Aerogen
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 GlaxoSmithKline plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Johnson & Johnson
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Koninklijke Philips N.V.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Merck & Co. Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Metall Zug AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Recipharm AB (publ)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Teva Pharmaceutical Industries Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Vectura Group plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Aerosol Delivery Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Aerosol Delivery Devices Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Aerosol Delivery Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Aerosol Delivery Devices Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Aerosol Delivery Devices Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Aerosol Delivery Devices Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Aerosol Delivery Devices Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Aerosol Delivery Devices (Dry Powder Inhalers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Aerosol Delivery Devices (Dry Powder Inhalers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Aerosol Delivery Devices (Metered Dose Inhalers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Aerosol Delivery Devices (Metered Dose Inhalers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Aerosol Delivery Devices (Nebulizers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Aerosol Delivery Devices (Nebulizers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Aerosol Delivery Devices (Asthma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Aerosol Delivery Devices (Asthma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Aerosol Delivery Devices (Chronic Obstructive Pulmonary Disease (COPD)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Aerosol Delivery Devices (Chronic Obstructive Pulmonary Disease (COPD)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Aerosol Delivery Devices (Cystic Fibrosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Aerosol Delivery Devices (Cystic Fibrosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Aerosol Delivery Devices (Non-Respiratory Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Aerosol Delivery Devices (Non-Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Aerosol Delivery Devices (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Aerosol Delivery Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Aerosol Delivery Devices (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Aerosol Delivery Devices (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Aerosol Delivery Devices (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Aerosol Delivery Devices (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Aerosol Delivery Devices Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Aerosol Delivery Devices Industry: SWOT Analysis
  • Figure 78: Global: Aerosol Delivery Devices Industry: Value Chain Analysis
  • Figure 79: Global: Aerosol Delivery Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Aerosol Delivery Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Aerosol Delivery Devices Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Aerosol Delivery Devices Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Aerosol Delivery Devices Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Aerosol Delivery Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Aerosol Delivery Devices Market: Competitive Structure
  • Table 7: Global: Aerosol Delivery Devices Market: Key Players